1
Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease
Condition(s): Cushing Disease Last Updated: October 18, 2012Active, not recruiting
19 Clinical Trials for: “Pituitary ACTH Hypersecretion”, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Condition(s): Cushing's Disease Last Updated: February 7, 2013Recruiting
3
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Condition(s): Cushing's Disease Last Updated: February 5, 2013Active, not recruiting
4
Safety and Efficacy of LCI699 in Cushing's Disease Patients
Condition(s): Cushing's Disease Last Updated: April 5, 2013Recruiting
5
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
Condition(s): Cushing's Disease Last Updated: March 22, 2013Recruiting
6
Preoperative Bexarotene Treatment for Cushing's Disease
Condition(s): Cushing's Disease Last Updated: May 26, 2011Recruiting
7
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition(s): Cushing's Disease Last Updated: July 27, 2012Terminated
8
Effects of Hormone Stimulation on Brain Scans for Cushing's Disease
Condition(s): Pituitary Neoplasm Last Updated: February 14, 2013Recruiting
9
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Condition(s): Pituitary Adenomas; Prolactinomas; Cushing's Disease Last Updated: November 16, 2011Recruiting
10
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Condition(s): Cushing's Disease; Cushing's Syndrome Last Updated: September 4, 2012Active, not recruiting
11
Long-term Cardiovascular Risk in Cured Cushing's Patients
Condition(s): Cushing's Disease Last Updated: March 5, 2010Withdrawn
12
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Condition(s): Cushing's Disease,; Acromegaly,; Neuroendocrine Tumors,; Pituitary Tumors; Ectopic ACTH Secreting (EAS) Tumors,; Dumping Syndrome,; Prostate Cancer,; Melanoma Negative for bRAF,; Melanoma Negative for nRAS Last Updated: February 15, 2013Not yet recruiting
13
Rhinological Outcomes in Endonasal Pituitary Surgery
Condition(s): Pituitary Neoplasm; Pituitary Adenoma; Prolactinoma; Cushings Disease; Acromegaly Last Updated: January 14, 2013Enrolling by invitation
14
Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Condition(s): Cushing's Disease; Corticotroph Adenoma Last Updated: April 28, 2009Completed
15
Cognition, Steroids, and Imaging in Cushings Disease
Condition(s): Cushing Syndrome Last Updated: February 12, 2010Completed
16
A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Condition(s): Cushing's Syndrome Last Updated: November 29, 2011Completed
17
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Condition(s): Cushing's Syndrome Last Updated: December 16, 2010Terminated
18
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition(s): Cushing's Syndrome Last Updated: August 10, 2012Active, not recruiting
19
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition(s): Cushing's Syndrome Last Updated: May 25, 2012Completed
